• LatestBTS Live: Seoul fights to ensure "bangtan" - bulletproof and safe show
  • LatestBTS Live: Seoul rehearses for comeback show with own digital and drone spectacle
  • LatestAnimuscure receives FDA orphan drug designation for ALS treatment candidate
  • LatestGULF CRISIS: Trump signals "winding-down" , Seoul joins statement on Iran
  • LatestBTS Live D-1: The world turns out in Seoul on eve of comeback concert
AJU PRESS ASIA NEWS HUB
  • Industry
  • Market
  • Policy
  • World Insights
  • Opinion
  • Entertainment
  • Visuals
  • AI PICK
  • KOR
  • JPN
Sign In

AJPlay

Latest

  • BTS Live: Seoul fights to ensure "bangtan" - bulletproof and safe show BTS Live: Seoul fights to ensure bangtan - bulletproof and safe show
  • BTS Live: Seoul rehearses for comeback show with own digital and drone spectacle BTS Live: Seoul rehearses for comeback show with own digital and drone spectacle
  • Animuscure receives FDA orphan drug designation for ALS treatment candidate Animuscure receives FDA orphan drug designation for ALS treatment candidate
  • GULF CRISIS: Trump signals "winding-down" , Seoul joins statement on Iran GULF CRISIS: Trump signals winding-down , Seoul joins statement on Iran
  • BTS Live D-1: The world turns out in Seoul on eve of comeback concert BTS Live D-1: The world turns out in Seoul on eve of comeback concert
  • BTS returns with 'ARIRANG,' draws mixed early response despite global hype BTS returns with ARIRANG, draws mixed early response despite global hype
  • BTS Live D-1: Gwanghwamun already bustling with crowds and excitement BTS Live D-1: Gwanghwamun already bustling with crowds and excitement
  • Last tanker to clear Hormuz before closure arrives in Korea Last tanker to clear Hormuz before closure arrives in Korea
  • KOSDAQ shines alone; Nikkei suffers "Black Friday" on Gulf crisis, hawkish BOJ KOSDAQ shines alone; Nikkei suffers Black Friday on Gulf crisis, hawkish BOJ
  • Samsung union chief: 'No. 1 means nothing without first-class treatment' Samsung union chief: No. 1 means nothing without first-class treatment
  • About
  • Copyright
  • Terms of Use
  • Privacy Statement
Mail : ajupress@ajunews.com

Copyright ⓒ AJU Press All rights reserved.